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abstract
 
In atrial myocytes, an initial exposure to isoproterenol (ISO) acts via cAMP to mediate a subsequent
 
acetylcholine (ACh)-induced activation of ATP-sensitive K
 
 
 
 current (I
 
K,ATP
 
). In addition, 
 
 
 
-adrenergic receptor
(
 
 
 
-AR) stimulation activates nitric oxide (NO) release. The present study determined whether the conditioning
effect of 
 
 
 
-AR stimulation acts via 
 
 
 
1
 
- and/or 
 
 
 
2
 
-ARs and whether it is mediated via NO signaling. 0.1 
 
 
 
M ISO plus
ICI 118,551 (ISO-
 
 
 
1
 
-AR stimulation) or ISO plus atenolol (ISO-
 
 
 
2
 
-AR stimulation) both increased L-type Ca
 
2
 
 
 
 cur-
rent (I
 
Ca,L
 
) markedly, but only ISO-
 
 
 
2
 
-AR stimulation mediated ACh-induced activation of I
 
K,ATP
 
. 1 
 
 
 
M zinterol (
 
 
 
2
 
-
AR agonist) also increased I
 
Ca,L
 
 and mediated ACh-activated I
 
K,ATP
 
. Inhibition of NO synthase (10 
 
 
 
M L-NIO), gua-
nylate cyclase (10 
 
 
 
M ODQ), or cAMP-PKA (50 
 
 
 
M Rp-cAMPs) attenuated zinterol-induced stimulation of I
 
Ca,L
 
and abolished ACh-activated I
 
K,ATP
 
. Spermine-NO (100 
 
 
 
M; an NO donor) mimicked 
 
 
 
2
 
-AR stimulation, and its ef-
fects were abolished by Rp-cAMPs. Intracellular dialysis of 20 
 
 
 
M protein kinase inhibitory peptide (PKI) abol-
ished zinterol-induced stimulation of I
 
Ca,L
 
. Measurements of intracellular NO ([NO]
 
i
 
) using the ﬂuorescent indi-
cator DAF-2 showed that ISO-
 
 
 
2
 
-AR stimulation or zinterol increased [NO]
 
i
 
. L-NIO (10 
 
 
 
M) blocked ISO- and
zinterol-induced increases in [NO]
 
i
 
. ISO-
 
 
 
1
 
-AR stimulation failed to increase [NO]
 
i
 
. Inhibition of G
 
i
 
-protein by
pertussis toxin signiﬁcantly inhibited zinterol-mediated increases in [NO]
 
i
 
. Wortmannin (0.2 
 
 
 
M) or LY294002
(10 
 
 
 
M), inhibitors of phosphatidylinositol 3
 
 
 
-kinase (PI-3K), abolished the effects of zinterol to both mediate
ACh-activated I
 
K,ATP
 
 and stimulate [NO]
 
i
 
. We conclude that both 
 
 
 
1
 
- and 
 
 
 
2
 
-ARs stimulate cAMP. 
 
 
 
2
 
-ARs act via two
signaling pathways to stimulate cAMP, one of which is mediated via G
 
i
 
-protein and PI-3K coupled to NO-cGMP sig-
naling. Only 
 
 
 
2
 
-ARs acting exclusively via NO signaling mediate ACh-induced activation of I
 
K,ATP
 
. NO signaling also
contributes to 
 
 
 
2
 
-AR stimulation of I
 
Ca,L
 
. The differential effects of 
 
 
 
1
 
- and 
 
 
 
2
 
-ARs can be explained by the cou-
pling of these two 
 
 
 
-ARs to different effector signaling pathways.
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INTRODUCTION
 
In general, autonomic nerve activity regulates cardiac
function in a reciprocal manner. However, less under-
 
stood are the mechanisms by which 
 
 
 
-adrenergic recep-
tor (
 
 
 
-AR)* stimulation inﬂuences the effects of subse-
quent muscarinic receptor stimulation. Previous work
from this laboratory (Wang and Lipsius, 1995) has
shown that in atrial myocytes, an initial exposure to iso-
proterenol (ISO) conditions the cell, such that a subse-
quent acetylcholine (ACh) exposure elicits a potenti-
ated increase in K
 
 
 
 conductance. The additional ACh-
activated K
 
 
 
 conductance exhibits inward rectiﬁcation
and is blocked by glibenclamide (GLIB), identifying it
as ATP-sensitive K
 
 
 
 current (I
 
K,ATP
 
). Therefore, these
ﬁndings indicate that after 
 
 
 
-AR stimulation, subse-
quent muscarinic receptor stimulation elicits activation
of two separate K
 
 
 
 conductances: ACh-activated K
 
 
 
 cur-
rent (I
 
K,ACh
 
) and I
 
K,ATP
 
. Functionally, this mechanism
may contribute to enhanced cholinergic inhibition of
atrial function following 
 
 
 
-AR stimulation. The condi-
tioning effects of ISO are dependent on cAMP-depen-
dent PKA signaling (Wang and Lipsius, 1995). However,
because ISO is a nonselective 
 
 
 
-AR agonist, it is not
clear whether the effects of ISO are mediated via 
 
 
 
1-
and/or 
 
 
 
2
 
-AR subtypes. Both types of 
 
 
 
-ARs are pres-
ent in cat atrial myocytes (Wang et al., 2000), and each
type exhibits signiﬁcantly different signal transduction
mechanisms (Steinberg, 1999; Xiao et al., 1999b). Al-
though 
 
 
 
1
 
-ARs are more abundant than 
 
 
 
2
 
-ARs, the pro-
portion of 
 
 
 
2
 
- to 
 
 
 
1
 
-ARs may be greater in atrial than
ventricular muscle (Buxton et al., 1987). In human
atrial muscle, the relative proportion of 
 
 
 
2
 
- to 
 
 
 
1
 
-ARs
has been reported at 20:80 (Brodde et al., 1983) and as
high as 50:50 (Robberecht et al., 1983). 
 
 
 
1
 
-ARs act ex-
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2
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K,ATP
 
 via NO Release
 
clusively via G
 
s
 
-proteins coupled to adenylate cyclase to
catalyze the synthesis of cAMP, which in turn activates
PKA. 
 
 
 
2
 
-AR signaling appears more diverse: 
 
 
 
2
 
-ARs cou-
ple to both G
 
s
 
- and G
 
i
 
-proteins (Xiao et al., 1995, 1999a;
Kilts et al., 2000). Moreover, in contrast to 
 
 
 
1
 
-ARs,
several studies indicate that 
 
 
 
2
 
-AR signaling acts locally
to regulate L-type Ca
 
2
 
 
 
 current (I
 
Ca,L
 
) via cAMP/PKA
activity, and is uncoupled from nonsarcolemmal regula-
tory proteins (Xiao and Lakatta, 1993; Xiao et al., 1994;
Altschuld et al., 1995; Skeberdis et al., 1997; Zhou et al.,
1997; Kuschel et al., 1999). These ﬁndings are consis-
tent with the idea that 
 
 
 
-AR regulation of I
 
Ca,L
 
 can result
from local or compartmentalized changes in cAMP
(Hohl and Li, 1991; Jurevi ius and Fischmeister, 1996),
and that 
 
 
 
-adrenergic regulation may correlate more
closely with particulate rather than global cAMP levels
(Hohl and Li, 1991). Much less is known about 
 
 
 
2
 
-AR
signaling in atrial muscle. In contrast to ventricular
muscle, 
 
 
 
2
 
-AR stimulation in human atrial muscle ap-
pears to exert global rather than local regulation of cel-
lular functions (Kaumann et al., 1996).
Another important consideration is that in cardio-
myocytes,   -AR stimulation activates NO production
(Kanai et al., 1997; Sterin-Borda et al., 1998; Balligand,
1999). However, the role of NO signaling in heart de-
pends on a variety of factors such as NO concentration,
concurrent  -adrenergic stimulation, tissue type, and
animal species (Balligand, 1999). In cat (Wang et al.,
1998) and human (Kirstein et al., 1995) atrial myo-
cytes, NO acts via cGMP-mediated inhibition of phos-
phodiesterase (PDE) type III activity to enhance cAMP-
dependent stimulation of ICa,L. Therefore, the purpose
of the present study was twofold: ﬁrst, to determine
whether  1- and/or  2-ARs are responsible for mediat-
ing ACh-induced activation of IK,ATP; and second, to de-
termine whether the conditioning effect of  -AR signal-
ing is mediated via NO signaling. The results indicate
that even though both  1- and  2-ARs stimulate cAMP
signaling, only  2-AR–stimulated cAMP mediated via
NO signaling induces ACh to activate IK,ATP. The differ-
ential effects of  1- and  2-ARs to regulate ion channel
function may be explained by the coupling of different
 -AR subtypes to different effector signaling pathways.
MATERIALS AND METHODS
Atrial myocytes were dispersed from adult cat atria using Lan-
gendorff perfusion and collagenase (type II; Worthington Bio-
chemical) digestion as previously reported (Wu et al., 1991). No
discernible differences were noted between left and right atrial
myocytes. Cells used for electrophysiological studies were trans-
ferred to a small tissue bath (0.3 ml) on the stage of an inverted
microscope (Nikon Diaphot) and superfused with a HEPES-
buffered modiﬁed Tyrode solution containing the following (in
mM): 145 NaCl, 4 KCl, 1 MgCl2, 2 CaCl2, 5 HEPES, and 11 glu-
cose, and titrated with NaOH to a pH of 7.4. Solutions were per-
fused by gravity and heated to 35   1 C. Atrial myocytes selected
c ˇ
for study were elongated and quiescent. Voltage and ionic cur-
rents were recorded using a nystatin (150  g/ml)-perforated
patch (Horn and Marty, 1988) whole-cell recording method
(Hamill et al., 1981). This method minimizes dialysis of intracel-
lular constituents with the internal pipette solution, and thereby
preserves physiological milieu and second messenger signaling
pathways. The internal pipette solution contained the following
(in mM): 100 potassium glutamate, 40 KCl, 1.0 MgCl2, 4 Na2-
ATP, 0.5 EGTA, and 5 HEPES, and titrated with KOH to pH 7.2.
A single suction pipette was used to record voltage (bridge
mode) or ionic currents (discontinuous voltage-clamp mode)
using an Axoclamp 2A ampliﬁer (Axon Instruments, Inc.). Com-
puter software (Pclamp; Axon Instruments, Inc.) was used to de-
liver voltage protocols, acquire, and analyze data. The effects of
ACh on K  conductance were studied as previously described
(Wang and Lipsius, 1995). In brief, an atrial cell was treated with
two consecutive exposures to ACh (ACh1 and ACh2) separated
by a 6-min recovery period in ACh-free Tyrode solution (see Fig.
1 A). Changes in total membrane conductance were assessed by
imposing voltage-clamp ramps (40 mV/s) between  130 and
 30 mV before, during, and after each ACh exposure. Voltage
ramps offer the advantage of a rapid method for measuring
peak ACh-induced currents throughout the voltage range. In
general, experimental interventions, such as exposure to ISO,
zinterol, or spermine-NO were imposed during the recovery pe-
riod between ACh1 and ACh2. In this way, we determined the ef-
fect of each intervention on ACh-induced K  conductances by
comparing the response to ACh2 in relation to ACh1. Measure-
ments of K  conductance were obtained at  130 and  30 mV.
The effects of each ACh exposure on K  conductance was fully
reversible (see Fig. 1 A). Previous work indicates that the control
currents do not affect the measurement of relative changes in
K  conductances induced by ACh2 in relation to ACh1 (Wang
and Lipsius, 1995). Therefore, in this study, ACh-induced K 
currents were measured without subtraction of control currents.
Control experiments indicate that an initial 30-s exposure to
ACh followed by a 6-min recovery period has no effect on the re-
sponse to a second ACh exposure (Wang and Lipsius, 1995).
Therefore, any changes in K  conductance elicited by ACh2 in
relation to ACh1 are attributed to the experimental intervention
imposed during the recovery interval. Previous work (Wang and
Lipsius, 1995) indicates that Ca2  inﬂux via ICa,L during  -AR
stimulation enhances ACh-induced activation of IK,ATP. There-
fore, ICa,L was activated during the interval between ACh expo-
sures by depolarizing voltage pulses from a holding potential of
 40 to 0 mV for 200 ms every 10 s. In some experiments, ICa,L
was studied alone by replacing potassium glutamate with cesium
glutamate in the pipette solution and adding 5 mM CsCl to the
external solutions to block K  conductances. In other experi-
ments, ICa,L was recorded using a ruptured patch recording
method to dialyze the cell interior with PKA inhibitors. PKA in-
hibitors were allowed to diffuse into the cell for  5 min before
recordings were performed. In these experiments, the internal
pipette solution contained the following (mM): 100 cesium
glutamate, 40 CsCl, 1 MgCl2, 4 NaATP, 0.5 EGTA, 10 HEPES,
and titrated with CsOH to pH 7.2. Unless stated otherwise,
zinterol was tested in the presence of 0.01–0.1  M atenolol to
ensure  2-AR stimulation. Cells were exposed to receptor antag-
onists for  4 min before exposure to agonists. Inhibition of Gi-
protein was achieved by incubating cells in pertussis toxin (PTX;
3.4  g/ml;  3 h; 36 C) and conﬁrmed by inhibition of ACh-
activated IK,ACh.
Direct measurements of intracellular NO ([NO]i) were ob-
tained by incubating cells with the ﬂuorescent NO-sensitive dye
4,5-diaminoﬂuorescein (DAF-2; Kojima et al., 1998; Nakatsubo et
al., 1998). Experiments were performed at room temperature.71 Wang et al.
Cells were exposed to the membrane-permeant DAF-2 diacetate
([DAF-2 DA]   5  M; Calbiochem) for 10 min at room tempera-
ture in 1 ml standard Tyrode solution. Cells were subsequently
washed for 10 min in Tyrode solution containing 100  M l-argi-
nine. DAF-2 ﬂuorescence was excited at 480 nm (F480). Emitted
cellular ﬂuorescence was recorded at 540 nm. Single cell ﬂuores-
cence signals were recorded with a photomultiplier tube (model
R2693; Hamamatsu Corp.) by masking individual cells with an
iris positioned in the emission path. Changes in cellular DAF-2
ﬂuorescence intensities (F) in each experiment were normalized
to the level of ﬂuorescence recorded before stimulation (Fo),
and changes in [NO]i are expressed as F/Fo. In the experiments
designed to measure [NO]i, solutions contained 100  M l-argi-
nine. l-arginine was omitted when L-NIO was used to block NO
synthase.
Drugs in this study include all of the following: isoproterenol,
acetylcholine chloride, glibenclamide, atenolol, PK inhibitor
(PKI), spermine-NO, l-N5-(1-iminoethyl)ornithine (L-NIO), 1H-
[1,2,4,]oxadiazolo[4,3- ]quinoxaline-1-one (ODQ), Wortman-
nin, LY294002, pertussis toxin (Sigma Chemicals); Rp-cAMPs,
4,5-diaminoﬂuorescein diacetate (DAF-2 DA; Calbiochem); zin-
terol (provided by Bristol-Myers Squibb), and ICI 118,551 (pro-
vided by AstraZeneca).
In general, results were obtained in cells from the same hearts
studied under control and test conditions. Data from two groups
of cells were analyzed using unpaired t test with signiﬁcance at
P   0.05. Data from multiple groups were analyzed using a one-
way analysis of variance (ANOVA) followed by a t-Newman-Keuls
test at P   0.05.
RESULTS
 -Adrenergic Receptor Subtypes
Fig. 1 A shows a typical experiment in which an atrial
myocyte was treated with two consecutive 30-s exposures
to 10  M ACh separated by a 6-min recovery period.
During the recovery period, the cell was exposed to 0.1
 M ISO, a nonselective  1/ 2-AR agonist, and ICa,L was
activated by voltage-clamp pulses (materials and
methods). As expected, ISO- 1/ 2-AR stimulation elic-
ited a marked increase in peak ICa,L above basal levels
( 258%; Fig. 1 A, inset). Both ACh1 and ACh2 expo-
sures elicited an increase in K  conductance. However,
after exposure to ISO, ACh2 induced a potentiated in-
crease in K  conductance compared with ACh1. As sum-
marized in Fig. 2, ISO- 1/ 2-AR stimulation increased
ICa,L by 266   78%, and ACh2 increased K  conduc-
tance compared with ACh1 by 31   10% (at  130 mV)
and 25   3% (at 30 mV), respectively (n   4; P   0.05).
These ﬁndings demonstrate that ISO elicits a condition-
ing effect that potentiates ACh2-induced K  conduc-
tance as previously reported (Wang and Lipsius, 1995).
The potentiated ACh2-induced K  conductance has
been identiﬁed as IK,ATP (Wang and Lipsius, 1995).
Figure 1. Current-voltage relationships
showing the effects of 0.1  M ISO (A–C) and
1  M zinterol (D) on ACh2-induced K  con-
ductance and ICa,L (insets). (A) ISO increased
ICa,L and mediated a potentiated increase in
ACh2-induced K  conductance compared with
ACh1. (B) In the presence of 0.01  M ICI
118,551, a  2-AR antagonist, ISO increased
ICa,L, but failed to potentiate ACh2-induced K 
conductance. (C) In the presence of 0.01  M
atenolol, a  1-AR antagonist, ISO increased
ICa,L and potentiated ACh2-induced K  con-
ductance. (D) Zinterol increased ICa,L and po-
tentiated ACh2-induced K  conductance. c;
control K  conductance before ACh1. r; recov-
ery after washout of ACh2. (insets) ICa,L calibra-
tion bars indicate 250 pA, 100 ms.72  2-AR Stimulation Mediates ACh-activated IK,ATP via NO Release
To determine whether the conditioning effect of ISO
was mediated via  1-ARs, the same protocol was repeated
by testing 0.1  M ISO in the presence of 0.01  M ICI
118,551, a selective  2-AR antagonist (O’Donnell and
Wanstall, 1980). As shown in Fig. 1 B, ISO- 1-AR stimula-
tion increased ICa,L markedly (372%, inset), but failed to
elicit a potentiated increase in ACh2-induced K  conduc-
tance. In fact, in this experiment, ACh2 elicited an in-
crease in K  conductance that was slightly smaller than
ACh1. As summarized in Fig. 2, ISO- 1-AR stimulation in-
creased ICa,L (239   48%), whereas ACh2 failed to elicit a
potentiated increase in K  conductance compared with
ACh1 (1   4% at  130 mV, and 0.5   3%, 30 mV; n  
8). In other words, ACh1 and ACh2 exposures induced
essentially the same increase in K  conductance, indicat-
ing that ISO did not affect IK,ACh. Similar results were ob-
tained when the concentration of ISO was raised to 1
 M (in the presence of 0.1  M ICI 118,551), i.e., stimu-
lation of ICa,L (395%) without potentiation of ACh2-
induced K  conductance (n   3).
To determine whether the effects of ISO are medi-
ated via  2-AR signaling, we tested the effects of ISO
plus 0.01  M atenolol, a selective  1-AR antagonist. Fig.
1 C shows that ISO- 2-AR stimulation increased ICa,L
(248%, inset) and mediated a potentiated increase in
ACh2-induced K  conductance. As summarized in Fig.
2, ISO- 2-AR stimulation increased ICa,L by 199   50%
and ACh2 increased K  conductance compared with
ACh1 by 27   6% ( 130 mV) and 29   3% (30 mV;
P   0.05; n   7). Additional experiments showed that
10  M glibenclamide, an inhibitor of IK,ATP, abolished
the effect of ISO- 2-AR stimulation to potentiate the
ACh2-induced K  conductance ( 2   9% at  130 mV,
and 0.5   5% at 30 mV) without affecting stimulation
of ICa,L (220   58%; n   4; not shown). This ﬁnding is
consistent with ACh2-induced activation of IK,ATP, as pre-
viously reported (Wang and Lipsius, 1995). The com-
bined presence of  1-AR (0.1  M atenolol) and  2-AR
(0.1  M ICI 118,551) antagonists abolished the effects
of 0.1  M ISO to both stimulate ICa,L (20   5%) and
mediate ACh-activated IK,ATP (4   10% at  130 mV,
and 0   3% at 30 mV; n   3). Further experiments
showed that 0.01  M BRL 37344, a  3-AR agonist
(Gauthier et al., 1999) failed to stimulate ICa,L or medi-
ate ACh-activated IK,ATP (n   5; not shown).
To further establish that selective  2-AR signaling is
responsible for the conditioning effect, we tested
zinterol, a selective  2-AR agonist. As shown in Fig. 1 D,
1  M zinterol increased ICa,L (273%; inset) and medi-
ated ACh2-induced activation of IK,ATP. As summarized in
Fig. 2, zinterol increased ICa,L by 159   17% and in-
creased ACh2-induced K  conductance compared with
ACh1 by 36   7% ( 130 mV) and 28   5% (30 mV; P  
0.05; n   16). To conﬁrm that zinterol acted via  2-AR
stimulation, 1  M zinterol was tested in the presence of
0.01   M ICI 118,551. Interestingly, this relatively low
concentration of ICI 118,551 abolished the effects of
zinterol to mediate ACh2-activated IK,ATP ([control]
23   3% vs. [ICI]  12   6% at  130 mV; and [con-
trol] 31   5% vs. [ICI]  1   3% at 30 mV) but only at-
tenuated zinterol-induced stimulation of ICa,L ([control]
193   84 vs. [ICI] 160   43%; not shown). Raising the
concentration of ICI 118,551 to 1  M also abolished
zinterol-induced stimulation of ICa,L ([control] 180% vs.
[ICI] 0.2%; n   6; not shown). These latter ﬁndings in-
dicate that the sensitivity of  2-ARs to mediate stimula-
tion of ICa,L is greater than to mediate ACh-activated
IK,ATP. This idea was explored further by testing a lower
Figure 2. Summary of the
effects of ISO (0.1  M) and
zinterol (0.1 and 1  M) on
ICa,L and ACh2-induced K 
conductances measured at
 130 and 30 mV. ISO- 1/ 2-
AR, ISO- 1-AR or ISO- 2-AR
stimulation each increased
ICa,L and only ISO- 1-AR stim-
ulation failed to potentiate
ACh2-induced K  conduc-
tances. In addition, even
though 0.1 and 1  M zinterol
increased ICa,L, the lower con-
centration of zinterol (0.1
 M) failed to potentiate
ACh2-induced K  conduc-
tance. (left ordinate) Percent
change in ICa,L above basal
levels. (right ordinate) Per-
cent change in K  conduc-
tance elicited by ACh2 com-
pared with ACh1.73 Wang et al.
(0.1  M) zinterol concentration. As summarized in Fig.
2, 0.1  M zinterol induced a typical increase in ICa,L
(152   31%), but failed to elicit a potentiated increase
in ACh2-induced K  conductance compared with ACh1
( 2   2% at  130 mV, and 1   3% at 30 mV; n   6).
Together, these results indicate that although stimula-
tion of  1- or  2-ARs both increase ICa,L markedly, only
 2-AR signaling selectively mediates ACh2-induced acti-
vation of IK,ATP. In addition, the effects of  2-AR stimula-
tion to mediate ACh-induced activation of IK,ATP and
stimulate ICa,L exhibit different signaling sensitivities. Fi-
nally,  3-ARs do not participate in the conditioning ef-
fect of  -AR stimulation.
Nitric Oxide Signaling
 -AR stimulation can induce NO release in cardiac
myocytes (Kanai et al., 1997). Therefore, we sought to
determine whether the conditioning effect of  2-AR stim-
ulation is mediated via NO signaling by testing zinterol
in the presence of 10  M L-NIO, an inhibitor of consti-
tutive NO synthase (Rees et al., 1990). The graph in
Fig. 3 A shows that in the absence of L-NIO (open
bars), zinterol elicited a typical increase in ICa,L (150  
21%) and a potentiated increase in ACh2-induced K 
conductance (52   20% at  130 mV, and 40   15% at
30 mV). In a second group of cells from the same
hearts, in the presence of L-NIO (Fig. 3 A, hatched
bars), zinterol-induced stimulation of ICa,L was attenu-
ated (121   31%), whereas ACh2-induced activation of
IK,ATP was abolished ( 6   2% at  130 mV, and  7  
2% at 30 mV) (n   12; P   0.05).
To determine whether NO signaling acts via cGMP,
we tested zinterol in the presence of 30  M ODQ, an
inhibitor of soluble guanylate cyclase (Garthwaite et al.,
1995). The graph in Fig. 3 B shows that compared with
control cells, ODQ also attenuated zinterol-induced
stimulation of ICa,L ([control] 177   27% vs. [ODQ]
111   13%) and abolished ACh2-induced activation of
IK,ATP ([control] 27   4% vs. [ODQ] 2   2% at  130
Figure 3. Effects of 1  M zinterol on ICa,L and ACh2-induced K  conductances in the absence (open bars) and presence (hatched bars)
of 10  M L-NIO (A), an inhibitor of NO synthase, and 10  M ODQ (B), an inhibitor of soluble guanylate cyclase. L-NIO (A) and ODQ
(B) each attenuated zinterol-induced stimulation of ICa,L and abolished the potentiation of ACh2-induced K  conductances. Ordinates are
the same as in Fig. 2.
Figure 4. Current-voltage relationships showing
the effects of 100  M spermine-NO (SNO) on
ACh-induced K  conductances in the absence (A)
and presence (B) of 10  M glibenclamide (GLIB).
(A) SNO elicited a potentiated increase in ACh2-
induced K  conductance. (B) GLIB blocked the
effect of SNO to mediate a potentiated increase in
ACh2-induced K  conductance. In the experiment
shown, at positive voltages, ACh2-induced K  con-
ductance was slightly smaller than ACh1. c; control
K  conductance before ACh1.74  2-AR Stimulation Mediates ACh-activated IK,ATP via NO Release
mV; and [control] 25   3% vs. [ODQ] 4   1% at 30
mV) (n   13; P   0.05).
If the conditioning effect of  2-AR stimulation results
from NO signaling, then exogenous NO should qualita-
tively mimic the effects of  2-AR stimulation. Spermine-
NO (SNO) spontaneously releases NO without the
production of other biologically active byproducts or
intermediates (Maragos et al., 1991). 100  M SNO
stimulated basal ICa,L as previously reported (Wang et al.,
1998), and mediated a potentiated increase in ACh2-
induced K  conductance compared with ACh1 (Fig. 4
A). In a total of six cells, SNO increased ICa,L by 240  
52% and potentiated ACh2-induced K  conductance by
32   7% ( 130 mV) and 26   5% (30 mV; P   0.05).
Moreover, 10  M GLIB had no signiﬁcant effect on
SNO-induced stimulation of ICa,L, but as shown in Fig. 4
B, it abolished ACh2-induced potentiation of K  con-
ductance ([control] 32   5% vs. [GLIB]  1   2% at
 130 mV; and [control] 30   7% vs. [GLIB]  6   7%
at 30 mV) (n   8; P   0.05). Note that at positive volt-
ages, ACh2-induced K  conductance was slightly smaller
than that induced by ACh1. These ﬁndings demonstrate
that exogenous NO mimics the effects of  2-AR stimula-
tion by stimulating ICa,L and mediating ACh2-induced
activation of IK,ATP. Together, these results indicate that
 2-AR stimulation acts via NO-cGMP signaling to medi-
ate ACh2-induced activation of IK,ATP. In addition, NO
signaling contributes to  2-AR stimulation of ICa,L.
In cat atrial myocytes, NO-cGMP signaling enhances
cAMP by inhibiting PDE type III activity (Wang et al.,
1998). To determine whether  2-AR–stimulated NO sig-
naling acts via cAMP to mediate ACh-induced activa-
tion of IK,ATP, we tested the effects of 100  M SNO and 1
 M zinterol in the absence and presence of 50  M Rp-
cAMPs, an inhibitor of cAMP-dependent PKA activity
(Van Haastert et al., 1984). In these experiments, cells
were externally superfused with Rp-cAMPs. The graph
in Fig. 5 A shows that compared with control cells
(open bars), Rp-CAMPs abolished SNO-induced stimu-
lation of both ICa,L ([control] 240   52% vs. [Rp-
cAMPs] 9   8%) and ACh2-activated IK,ATP (32   7% vs.
0   3% at  130 mV, and 26   5% vs. 5   3% at 30 mV;
P   0.05). Interestingly, when the same experiment was
performed with zinterol, compared with control re-
sponses (open bars), Rp-cAMPs only attenuated zin-
terol-induced stimulation of ICa,L ([control] 123   24%
vs. [Rp-cAMPs] 98   25%) while completely blocking
ACh2-induced activation of IK,ATP (29   5% vs. 0   1%
at  130 mV; and 19   2% vs. 1   2% at 30 mV) (n  
14; P   0.05). These results indicate that inhibition of
cAMP-dependent PKA by Rp-cAMPs effectively abol-
ishes NO-mediated signaling. Moreover, NO signaling
stimulated by  2-ARs acts via cAMP to mediate ACh-
induced activation of IK,ATP and contributes to stimula-
tion of ICa,L. The fact that inhibition of PKA abolished
SNO-induced stimulation of ICa,L but only attenuated
 2-AR stimulation of ICa,L suggests that  2-AR signaling
regulates ICa,L, in large part, via a mechanism that is in-
dependent of NO signaling.
In other words, after blockade of NO signaling,  2-
AR stimulation still stimulates ICa,L by at least 100%
above basal levels. This NO-independent effect of  2-
AR stimulation could still be mediated by cAMP. It may
not be inhibited by Rp-cAMPs because external applica-
tion of Rp-cAMPs cannot reach high enough levels in-
tracellularly to compete with cAMP and/or to access a
separate cAMP compartment. To address this issue, we
determined the effect of zinterol to regulate ICa,L using
a ruptured patch method to dialyze the cell interior
with either 100  M Rp-cAMPs or 20  M cAMP-depen-
dent PKA inhibitory peptide (PKI). This method al-
lows better access to intracellular compartments and
achieves a higher concentration of inhibitor intracellu-
larly. Cells dialyzed without (control) and with drugs
Figure 5. Effects of spermine-NO (SNO; A) and zinterol (ZINT; B) on ICa,L and ACh2-induced K  conductances in the absence (open
bars) and presence (hatched bars) of 50  M Rp-cAMPs. (A) Rp-cAMPs abolished the effects of 100  M SNO to both increase ICa,L and to
mediate a potentiated increase in ACh2-induced K  conductance. (B) Rp-cAMPs attenuated the effect of 1  M zinterol to increase ICa,L and
abolished the effect of zinterol to mediate a potentiated increase in ACh2-induced K  conductance. Ordinates are the same as in Fig. 2.75 Wang et al.
were compared. Intracellular Rp-cAMPs elicited a sig-
niﬁcantly greater inhibition of 1  M zinterol-induced
stimulation of ICa,L ([control] 140   32% vs. [Rp-
cAMPs] 54   11%) (n   10; P   0.05; not shown). In
addition, intracellular PKI essentially abolished the ef-
fect of 1  M zinterol to stimulate ICa,L ([control] 188  
17% vs. [Rp-cAMPs] 18   6%; n   6; P   0.05) and al-
most completely blocked 0.1  M ISO-induced stimula-
tion of ICa,L ([control] 176   27% vs. [PKI] 25   6%)
(n   6; P   0.05; not shown). These ﬁndings indicate
that  2-AR stimulation of ICa,L is mediated entirely via
cAMP. Therefore, the  2-AR–mediated stimulation of
ICa,L that remains after blockade of NO signaling is me-
diated via cAMP. Together, the present ﬁndings suggest
that  2-ARs generate cAMP via two different signaling
pathways; NO-dependent and NO-independent.
Intracellular Nitric Oxide Release
In the following experiments, we used the NO indicator
DAF-2 to directly visualize changes in intracellular NO
concentration ([NO]i). Fig. 6 (A–D) shows the effects
of 1  M ISO ( 1/ 2-AR stimulation, Fig. 6 A), 1  M ISO
in the presence of 0.1  M atenolol ( 2-AR stimulation,
Fig. 6 B), 1  M ISO in the presence of 0.1  M ICI
118,551 ( 1-AR stimulation, Fig. 6 C), and 1  M ISO in
the presence of 10  M L-NIO (Fig. 6 D). In each exper-
iment, the cells were ﬁeld-stimulated at 1 Hz. ISO alone
(Fig. 6 A) and ISO- 2-AR stimulation (Fig. 6 B) both in-
creased [NO]i. ISO- 1-AR stimulation (Fig. 6 C) failed
to increase [NO]i. However, exposure to 100  M SNO
elicited a prominent increase in [NO]i, indicating that
the NO indicator was functional (Fig. 6 C). ISO-medi-
ated stimulation of [NO]i was abolished by pretreat-
ment with 10  M L-NIO (Fig. 6 D). These ﬁndings indi-
cate that ISO acts via  2-ARs, but not  1-ARs, to activate
NO release. As shown in Fig. 7 (A–D) the effects of  2-
AR stimulation on [NO]i was further examined by test-
ing zinterol. Fig. 7 A shows that ﬁeld stimulation (FS, ar-
row) alone had no effect on [NO]i. During ﬁeld stimu-
lation, however, exposure to 10  M zinterol increased
[NO]i (Fig. 7 A). Zinterol-mediated increases in [NO]i
were abolished by blocking  2-ARs with ICI 118,551
(Fig. 7 B) or by blocking NOS with 10  M L-NIO (Fig. 7
C). Fig. 7 D shows the effects of three different zinterol
concentrations (10, 1, and 0.1  M) on [NO]i. Zinterol
induced a dose-dependent increase in [NO]i. The
graph in Fig. 8 (A and B) summarizes the effects of 1
 M ISO and 10  M zinterol on [NO]i (Fig. 8 A) and the
Figure 6. Effects of 1  M ISO on [NO]i. (A) ISO- 1/ 2-AR stimulation increased [NO]i. (B) ISO- 2-AR increased [NO]i. (C) ISO- 1-AR
had no effect on [NO]i, although 100  M SNO elicited a prominent increase in [NO]i. (D) L-NIO blocked ISO- 1/ 2-AR effects on [NO]i.76  2-AR Stimulation Mediates ACh-activated IK,ATP via NO Release
Figure 7. Effects of zinterol on [NO]i. (A) Field stimulation (FS, arrow) had no effect on [NO]i. However, during ﬁeld of stimulation,
exposure to 10  M zinterol in the presence of 0.1  M atenolol, increased [NO]i. (B) Pretreatment with 0.1  M ICI 118,551 blocked the ef-
fect of zinterol to increase [NO]i. (C) Pretreatment with 10  M L-NIO blocked the effect of zinterol to increase [NO]i. (D) Zinterol (10, 1,
and 0.1  M) elicited a dose-dependent increase in [NO]i.
Figure 8. Summary of the effects of 1  M ISO and 10  M zinterol on [NO]i. (A) The effects of ISO and zinterol to increase [NO]i (con-
trol) were not signiﬁcantly affected by  1-AR block (0.1  M atenolol), but the effects of both agonists were abolished by  2-AR block (ICI
118,551) or inhibition of NO synthase (L-NIO). (B) The effects of three different zinterol concentrations (10, 1, and 0.1  M) on [NO]i.
The numbers in parentheses indicate the number of cells tested.77 Wang et al.
dose-dependent effects of zinterol (Fig. 8 B). Both ISO
and zinterol increased [NO]i (open bars). Although
each response was slightly decreased by 0.1  M aten-
olol, compared with control, the differences were not
statistically signiﬁcant. This concentration of atenolol
may have exerted some  2-AR blockade. Nevertheless,
the effects of ISO and zinterol were abolished by  2-AR
blockade (0.1  M ICI 118,551) or inhibition of NOS
(10  M L-NIO). Fig. 8 B summarizes the dose–response
for the three different zinterol concentrations tested. At
0.1  M zinterol, only three out of six cells elicited a
small increase in [NO]i. Further experiments showed
that the  3-AR agonist BRL 37344 (0.01  M) failed to
increase [NO]i (not shown). Together, these ﬁndings
are consistent with the present electrophysiological
ﬁndings that stimulation of  2-ARs, but not  1-ARs or  3-
ARs, act via NO signaling to mediate ACh-induced acti-
vation of IK,ATP and to stimulate ICa,L.
Finally, we sought to gain further insight into the sig-
naling pathway through which  2-ARs stimulate NO
production and mediate ACh-induced activation of
IK,ATP. We determined whether the effect of  2-ARs to
release NO is mediated via Gi-protein by testing cells in-
cubated in PTX (materials and methods). Fig. 9 A
shows the effect of 10  M zinterol on a control cell and
second cell obtained from the same heart incubated in
PTX. Under control conditions, zinterol elicited a typi-
cal increase in [NO]i. In the PTX-treated cell, zinterol-
induced stimulation of NO production was markedly
decreased. The graph in Fig. 9 B summarizes the effects
of zinterol to increase [NO]i in control (1.1   0.02;
n   9) and PTX-treated cells (1.0   0.01; n   17),
and shows that compared with control, pretreatment
with PTX signiﬁcantly (P   0.001) inhibited zinterol-
induced stimulation of NO. These ﬁndings suggest that
 2-ARs act via Gi-protein to stimulate NO release.
In endothelial cells, stimulation of phosphatidylinosi-
tol 3 -kinase (PI-3K) signaling activates AKt (PKB)-
mediated phosphorylation of eNOS, resulting in the
production of NO (Dimmeler et al., 1999; Fulton et al.,
1999). To examine the role of PI-3K, we incubated
atrial cells in 0.2  M Wortmannin, an inhibitor of PI-
3K, for  30–45 min. In a control cell (Fig. 10 A), 1  M
zinterol mediated a typical ACh2-induced activation of
IK,ATP. In another cell from the same heart (Fig. 10 B),
pretreatment with Wortmannin abolished the effect of
zinterol to mediate ACh2-induced activation of IK,ATP.
Comparing control (n   3) and Wortmannin-treated
cells (n    4) showed that Wortmannin (wort) abol-
ished the potentiated increase in ACh2-induced K 
conductance ([control] 37   8% vs. [wort] 0.3   1% at
 130 mV; and [control] 36   11% vs. [wort] 4   4% at
30 mV) (P     0.05). Additional experiments showed
that 10  M LY294002 (LY), a speciﬁc PI-3K inhibitor
that acts via a different mechanism than Wortmannin
(Vlahos et al., 1994), also abolished the potentiated in-
crease in ACh2-induced K  conductance ([control] 18  
2% vs. [LY]  0.1   2% at  130 mV; and [control]
24   4% vs. [LY]  7   1% at 30 mV) (n   8; P   0.05;
not shown). Furthermore, as shown in Fig. 10 C, in a
control cell, 10  M zinterol increased [NO]i and in a
cell pretreated with Wortmannin, the zinterol-medi-
ated increase in [NO]i was abolished. As summarized
in Fig. 10 D, compared with control (1.2   0.5; n   4),
Wortmannin (1.0   0.2; n   3) or LY294002 (0.9   02;
n   5; P   0.05) abolished zinterol-mediated increases
in [NO]i. These ﬁndings indicate that  2-ARs act via PI-
3K signaling to activate NO production that, in turn,
mediates ACh-activated IK,ATP.
DISCUSSION
Our previous work indicates that in cat atrial myocytes,
an initial exposure to ISO acts via cAMP signaling to
mediate a subsequent ACh-induced activation of IK,ATP
(Wang and Lipsius, 1995). The present ﬁndings extend
our previous work by elucidating several new underly-
ing mechanisms: (1) the conditioning effect of  -AR
stimulation acts selectively via  2-ARs rather than the
predominant  1-AR signaling pathway; (2)  2-ARs act
via Gi-protein and PI-3K coupled to NO-cGMP-cAMP
signaling to mediate ACh-induced activation of IK,ATP;
Figure 9. Effect of pertus-
sis toxin (PTX) on zinterol-
mediated stimulation of NO.
(A) Under control condi-
tions, 10  M zinterol elicited
a typical increase in [NO]i.
In another cell incubated
in PTX, zinterol-induced in-
crease in [NO]i was markedly
decreased. (B) Graph sum-
marizing the effects of 10  M
zinterol on control and PTX-
treated cells. The numbers in
parentheses indicate the
number of cells tested.78  2-AR Stimulation Mediates ACh-activated IK,ATP via NO Release
and (3) NO signaling contributes to  2-AR stimulation
of ICa,L. In addition, to the best of our knowledge, this is
the ﬁrst report in adult atrial myocytes to demonstrate
direct measurements of [NO]i, and that Gi-protein and
PI-3K signaling are coupled to NO production.
Perhaps one of the most surprising ﬁndings of the
present study is that although  1- and  2-AR subtypes
both stimulate cAMP, only cAMP stimulated by  2-ARs
mediated ACh-activated IK,ATP. Moreover, only cAMP
generated via NO signaling could mediate ACh-acti-
vated IK,ATP. The fact that  2-AR–mediated stimulation of
ICa,L and ACh-activated IK,ATP could be regulated, to a
large extent, independently of one another suggests that
 2-ARs act via two different signaling pathways. Indeed,
partial blockade of PKA activity (Rp-cAMPs), or  2-
ARs (ICI 118,551), or complete block of NO signaling
(L-NIO or ODQ) abolished ACh-activated IK,ATP, whereas
 2-AR stimulation of ICa,L persisted. Similarly, low con-
centrations of zinterol stimulated ICa,L without inducing
ACh-activated IK,ATP. The ability of  2-ARs to stimulate
ICa,L without mediating ACh-activated IK,ATP is essentially
the same as the response to  1-AR stimulation. Because
 1-ARs are exclusively coupled via Gs-proteins to ade-
nylate cyclase (Barr et al., 1997), it seems reasonable to
assume that the  2-AR signaling pathway that acts inde-
pendently of NO signaling also is mediated via Gs-ade-
nylate cyclase. This is supported by the present ﬁndings
that inhibition of cAMP-dependent PKA (dialysis with
PKI) abolished  2-AR–mediated stimulation of ICa,L.
Therefore, we conclude that  2-ARs stimulate cAMP via
two distinct signaling pathways: (1) Gs-protein coupled
directly to adenylate cyclase, which is NO-independent;
and (2) NO-cGMP–mediated inhibition of PDE type III
activity (Fig.11). The latter pathway is consistent with
Figure 10. Effects of Wortmannin, an inhibitor of PI-3K, on ACh-induced activation of IK,ATP (A and B) and production of [NO]i (C and
D). (A) Under control conditions, after exposure to 1  M zinterol, ACh2 induced a typical potentiated increase in K  conductance. (B) In
another cell, pretreatment with 0.2  M Wortmannin abolished the potentiated response to ACh2. (C) Under control conditions, 10  M
zinterol stimulated [NO]i. In another cell, pretreatment with 0.2  M Wortmannin abolished zinterol-mediated stimulation of [NO]i. (D)
Summary graph showing that compared with control, pretreatment with either 0.2  M Wortmannin (wort) or 10  M LY294002 (LY)
blocked zinterol-induced stimulation of [NO]i. The numbers in parentheses indicate the number of cells tested.79 Wang et al.
our previous work in cat atrial myocytes, which indicates
that NO signaling stimulates ICa,L via cGMP-mediated in-
hibition of PDE type III (Wang et al., 1998). 
The present work further indicates that stimulation
of Gs-adenylate cyclase by either  1- or  2-ARs generates
a pool of cAMP that is unable to mediate ACh-induced
activation of IK,ATP. In other words, stimulation of Gs-
adenylate cyclase and NO signaling generate distinct
compartments of cAMP. It is now well established that
compartmentation of signaling molecules by scaffold-
ing proteins can localize signaling mechanisms to spe-
ciﬁc intracellular sites (Couet et al., 1997; Okamoto et
al., 1998; Steinberg and Brunton, 2001). For example,
caveolin contained within caveolae membranes acts to
anchor several important signaling components such as
 2-ARs, G  subunits, eNOS, and isoforms of adenylate
cyclase and PKC. In contrast,  1-ARs are thought to be
largely excluded from caveolae (Steinberg and Brun-
ton, 2001). Moreover, other signaling components
that exist in ﬁxed spacial domains, such as A-kinase an-
choring proteins, PKA regulatory subunits, phosphodi-
esterases, and phosphoprotein phosphatases, target
cAMP signaling (Steinberg and Brunton, 2001). In-
deed, Jurevi ius and Fischmeister (1996) demonstrated
that in frog ventricular myocytes,  -AR stimulation by
ISO acts locally to stimulate ICa,L via local elevation of
cAMP, and that local PDE activity targets cAMP signal-
ing to the channel. In the present study, the fact that
exogenous NO, which is expected to raise global NO
levels, mimicked the effects of  2-receptor–mediated
stimulation suggests that NO signaling targets speciﬁc
PDE III activity colocalized with PKA to target cAMP lo-
cally generated by endogenous adenylate cyclase activ-
ity (Fig. 11). This is consistent with localized regulation
by NO signaling (Dittrich et al., 2001). Moreover, inhi-
c ˇ
bition of phosphodiesterase activities reduces the local
response to  -adrenergic stimulation (Hohl and Li,
1991; Jurevi ius and Fischmeister, 1996). This may ex-
plain why NO signaling induces ACh-activated IK,ATP as
well as some stimulation of ICa,L. It is interesting to note
that unlike  1-AR stimulation, forskolin, a direct stimu-
lator of adenylate cyclase, or 8-CPT-cAMP, a membrane-
permeant analogue of cAMP, both elicit ACh-induced
activation of IK,ATP equivalent to that of  2-AR stimula-
tion (Wang and Lipsius, 1995). Apparently, by raising
intracellular cAMP to unphysiologically high levels,
these agents probably ﬂood restricted signaling com-
partments obscuring the delicate regulatory mecha-
nisms that normally exist within the cell. This interpre-
tation is supported by the ﬁndings that local applica-
tion of ISO elicits local stimulation of ICa,L, whereas a
similar exposure to forskolin stimulates ICa,L through-
out the cell (Jurevi ius and Fischmeister, 1996).
In the present study, only  2-AR signaling activated
NO release. In rat ventricular myocytes both,  1- and  2-
ARs stimulate NO release with  1-ARs being more effec-
tive than  2-ARs (Kanai et al., 1997). In rat atria, ISO
stimulates NOS activity and the production of cGMP
(Sterin-Borda et al., 1998), although different  -AR sub-
types were not studied. The present results also indicate
that stimulation of  3-ARs failed to stimulate ICa,L or me-
diate ACh-activated IK,ATP, suggesting that this  -AR sub-
type is not involved in the conditioning effect of  -AR
stimulation. In various animal species, including human
(Gauthier et al., 1999), stimulation of  3-ARs in ventric-
ular muscle decreases contractility and in humans is
presumably mediated via activation of an NOS pathway
(Gauthier et al., 1998). The lack of  3-AR response in
cat atria may be species-dependent and/or due to dif-
ferences between atrial and ventricular muscle. NO sig-
c ˇ
c ˇ
Figure 11. Schematic diagram summarizing the signaling pathways coupled to both  1- and  2-ARs in cat atrial myocytes.  1-ARs couple
exclusively via Gs-protein to adenylate cyclase (AC) to stimulate cAMP synthesis.  2-ARs also couple via Gs-protein to AC to stimulate cAMP.
Whether both  1- and  2-ARs are coupled to the same Gs-AC remains to be determined.  2-ARs also couple via Gi-protein and PI-3K/Akt
signaling to constitutive NO synthase (eNOS) and production of NO. NO stimulates guanylate cyclase (GC) to elicit cGMP-induced inhibi-
tion of PDE III, which raises cAMP generated by endogenous AC activity. Compartmentalized pools of cAMP generated via different  1-
and  2-AR–mediated signaling pathways target regulation of L-type Ca2  channels (ICa,L) and ACh-activated ATP-sensitive K  channels
(IK,ATP). M1-R indicates subtype 1 muscarinic receptor.80  2-AR Stimulation Mediates ACh-activated IK,ATP via NO Release
naling also exerts both negative as well as positive effects
on  -adrenergic stimulation depending on various fac-
tors such as NO concentration, tissue type, and animal
species (Balligand, 1999). The present results show that
inhibition of NO signaling attenuated  2-AR–induced
stimulation of ICa,L, indicating that NO contributes to
the stimulatory effects of  2-AR signaling. This is consis-
tent with the effects of NO signaling in both cat (Wang
et al., 1998) and human (Kirstein et al., 1995) atrial
muscle to stimulate ICa,L via cGMP-mediated inhibition
of PDE type III and elevation of cAMP.
The present results also demonstrate that  2-ARs stim-
ulate NO production via PTX-sensitive Gi-protein, which
is consistent with reports that  2-ARs are coupled to both
Gs- and Gi-proteins (Xiao et al., 1995, 1999a; Kilts et al.,
2000). In addition, the ability of  2-ARs to mediate both
stimulation of NO and ACh-induced activation of IK,ATP
was abolished by blocking PI-3K signaling with either
Wortmannin or LY294002. In endothelial cells, Akt is a
downstream effector of PI-3K signaling, and can phos-
phorylate eNOS and stimulate production of NO (Ful-
ton et al., 1999). Inhibition of PI-3K/Akt signaling or
mutation of Akt sites on eNOS prevents activation of
eNOS (Dimmeler et al., 1999). In fact, after submission
of the present study, Vila Petroff et al. (2001) reported,
in rat ventricular myocytes, that stretch-induced release
of endogenous NO is mediated via PI-3K/Akt signaling.
Moreover, in rat neonatal ventricular myocytes,  2-AR
stimulation protects from apoptosis via PI-3K/Akt signal-
ing (Chesley et al., 2000). PI-3K/Akt signaling and pro-
tection from apoptosis were prevented by inhibition of
Gi-protein (PTX), indicating that  2-ARs act via Gi- to
mediate PI-3K/Akt signaling. Therefore, we conclude
that in cat atrial myocytes  2-ARs are coupled via Gi-pro-
tein and PI-3K/Akt signaling to eNOS and the produc-
tion of NO (Fig. 11). This would explain the present
ﬁnding that  1-ARs, which couple exclusively to Gs-pro-
tein, fail to mediate NO release. In addition, activation
of PI-3K/Akt signaling is associated with enhanced cell
survival (Kennedy et al., 1997; Datta et al., 1999), and
NO signaling is a key mechanism in the cardioprotec-
tion conferred by ischemic preconditioning (Ping et al.,
1999). Therefore, we speculate that  2-AR stimulation
acts via NO signaling to exert cardioprotective and/or
antiapoptotic effects.
The effect of ISO to mediate ACh-activated IK,ATP is
enhanced by Ca2  inﬂux via ICa,L and is dependent on
Ca2  uptake and release from the SR (Wang and Lip-
sius, 1995). Based on these ﬁndings, we previously pro-
posed that the conditioning effect of  -AR stimulation
depended on cAMP to stimulate Ca2  handling. How-
ever, this idea is difﬁcult to reconcile with the present
ﬁndings, which show that only cAMP generated exclu-
sively via  2-AR–mediated NO signaling is capable of in-
ducing ACh-activated IK,ATP. In other words,  1-AR stim-
ulation of cAMP would certainly be expected to stimu-
late Ca2  handling, and yet it fails to mediate ACh-
induced activation of IK,ATP. Therefore, it appears that
local NO-cAMP signaling must target additional sites
that are more intimately related to cholinergic regula-
tion of ATP-sensitive K  channels.
The present ﬁndings indicate that stimulation of the
NO-dependent signaling pathway through which  2-
ARs mediate ACh-activated IK,ATP is less sensitive than
the NO-independent (Gs-) signaling pathway through
which  2-ARs primarily regulate ICa,L. NO production
may need to reach a critical threshold before it can
raise cAMP concentrations sufﬁciently. This is sup-
ported by the present ﬁnding that although low con-
centrations of zinterol (0.1  M) were capable of gener-
ating small amounts of [NO]i, they failed to mediate
ACh-induced activation of IK,ATP. A similar argument
could not explain the inability of ISO- 1-AR stimulation
to elicit ACh-activated IK,ATP or stimulate [NO]i because
1   M ISO should have maximally stimulated  1-ARs
(Marsh and Smith, 1985). Functionally, the lower sensi-
tivity of  2-AR–mediated NO signaling indicates that
this mechanism is probably invoked in response to rela-
tively high levels of  -AR stimulation. As a result,  2-
AR–mediated NO signaling would augment stimula-
tion of ICa,L and, at the same time, condition the cell for
subsequent enhanced cholinergic inhibition of atrial
function via ACh-induced activation of IK,ATP. Estimates
indicate that  1 nS/cell or  1% of the available con-
ductance of ATP-sensitive K  channels is sufﬁcient to
shorten action potential duration by 50% (Nichols and
Lederer, 1991). In the present study, IK,ATP activated by
ACh represents an additional K  conductance of  2–4
nS/cell (at 0 mV). This should elicit a profound short-
ening in action potential duration, resulting in a strong
negative inotropic response and rapid termination of
prior   -AR stimulation. This rapid termination may
provide some protection from Ca2  overload that could
result from  -adrenergic-induced Ca2  inﬂux.
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